• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Health Professionals

  • Print
  • Share
  • E-mail

2014 Health Professional Organizations Annual Conference

The FDA Office of Health and Constituent Affairs (OHCA), Health Professional Liaison Program is hosting the Third Annual Health Professional Organizations Conference in collaboration with the Center for Drug Evaluation and Research (CDER), the Center for Devices and Radiological Health (CDRH), and the Center For Tobacco Products (CTP) on May 14, 2014, from 8:15 a.m. to 12:00 p.m. at the FDA White Oak Campus in Silver Spring, Maryland.

Slide presentations offered in pdf format where available.


FDA Health Professional Liaison Program logo

 

Welcome, FDA Health Professional Liaison Program

 

Introductory Remarks

  • Margaret A. Hamburg, MD
    Commissioner of Food and Drugs 

 

FDA Town Hall Panel

  • Moderator: Stephanie Joseph, MPH
    Health Programs Coordinator, Health Professional Liaison Program, OHCA
  • Michelle McMurry-Heath, MD, PhD
    Associate Director for Science, Center for Devices and Radiological Health (CDRH)
  • Richard A. Moscicki, MD
    Deputy Director for Science Operations, Center for Drug Evaluation and Research (CDER)
  • Mitch Zeller, JD
    Director, Center for Tobacco Products (CTP)
  • Stephen Ostroff, MD
    Acting Chief Scientist, Office of the Chief Scientist, Office of the Commissioner (OC)

 

Update on the Development and Approval of Biosimilar Products: Where We Are Now and Where are We Headed?

  • Sue Lim, MD
    Office of New Drugs, CDER, Therapeutic Biologics and Biosimilars Team (TBBT) 

 

Using Data and Analysis to Promote the Public Health at FDA

 

Closing Remarks

  • Anna M. Fine, PharmD, MS
 
-